System Transmission

Top Signal

100#1 JOB

Activity

2178Ripe

+919 today

System

Live1m

Terminal Asset View

stockNASDAQ

ANAB

$64.81+1.60%

AnaptysBio Inc. - Common Stock

Ripening

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

56Ripening

Live Analysis Active

Company Mission

AnaptysBio creates antibody-based medicines that target specific proteins in the body to treat autoimmune diseases and cancer. These medicines are designed for patients who need new treatment options when existing therapies don't work well enough. The company makes money through partnerships with larger pharmaceutical companies and could earn revenue from drug sales if its treatments receive approval.

ANA

Industry Context

The biotechnology industry focuses on developing medical treatments using biological systems. Companies in this space often work on innovative therapies for serious diseases, with success depending on clinical trial results and regulatory approvals. Antibody-based treatments have become increasingly important for autoimmune conditions and cancer.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

29Matrix

Market Momentum

66.7— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.2x— Normal Volume

Today's Change

1.60%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ANAB across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 08:57 PM UTC

As-of 03-14-2026 20:42 UTC

Develops antibody drugs for immune system diseases and makes money by partnering with larger pharmaceutical companies to advance treatments.

Price is compressing on the weekly chart near recent levels, suggesting potential volatility expansion soon showing consolidation pattern.

Biotech sector showing renewed interest in antibody therapies, which could benefit companies with promising clinical pipelines.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...